Shuttle Pharmaceuticals Holdings (SHPH) Assets Average (2022 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Assets Average of $11.1 million for Q1 2026, up 185.11% year-over-year from $3.9 million in Q1 2025, and up 58.97% quarter-over-quarter from $7.0 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Assets Average (2022 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Assets Average history runs 5 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- In Q1 2026, Assets Average rose 185.11% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $11.1 million (up 185.11% YoY), while the FY2025 annual figure was $6.5 million, up 53.49% from the prior year.
- Assets Average for Q1 2026 stood at $11.1 million, up from $7.0 million in the prior quarter.
- The five-year high for Assets Average was $11.1 million in Q1 2026, with the low at $1.6 million in Q4 2024.
- The 5-year median for Assets Average is $6.0 million (2023), against an average of $6.2 million.
- The sharpest annual moves came in 2024 and 2025: Assets Average tumbled 78.5% in 2024, then jumped 340.87% in 2025.
- Shuttle Pharmaceuticals Holdings' Assets Average stood at $9.0 million in 2022, then declined by 26.1% to $6.7 million in 2023, then sank by 76.14% to $1.6 million in 2024, then soared by 340.87% to $7.0 million in 2025, then soared by 58.97% to $11.1 million in 2026.
- Business Quant data shows SHPH's Assets Average at $11.1 million in Q1 2026, $7.0 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | 11.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.14 Mn |
| Dec 31, 2025 | 7.01 Mn |
| Sep 30, 2025 | 4.52 Mn |
| Jun 30, 2025 | 5.41 Mn |
| Mar 31, 2025 | 3.91 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | 5.35 Mn |
| Dec 31, 2023 | 6.66 Mn |
| Sep 30, 2023 | 8.11 Mn |
| Jun 30, 2023 | 9.64 Mn |
| Mar 31, 2023 | 9.55 Mn |
| Dec 31, 2022 | 9.02 Mn |